Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
26.42
-1.27 (-4.59%)
At close: Dec 5, 2025, 4:00 PM EST
26.41
-0.01 (-0.04%)
After-hours: Dec 5, 2025, 7:53 PM EST
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.72 billion as of December 5, 2025. Its market cap has increased by 51.27% in one year.
Market Cap
1.72B
Enterprise Value
1.33B
1-Year Change
51.27%
Ranking
Category
Stock Price
$26.42
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.72B, an increase of 169.51%. That is a compound annual growth rate of 22.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.80B | 73.01% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 909.25B |
| Johnson & Johnson | 488.12B |
| AbbVie | 404.06B |
| UnitedHealth Group | 301.74B |
| AstraZeneca | 279.81B |
| Novartis AG | 257.47B |
| Merck & Co. | 252.01B |
| Abbott Laboratories | 217.05B |